Home LiteratureArticle Details
PMID: 20485289 Published · ppublish English Journal Article

Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells.

British journal of cancer ·Vol. 102 ·No. 12 ·2010-06-08 ·Pages 1746-52

Madhok BM, Yeluri S, Perry SL, Hughes TA, Jayne DG

Abstract

Cancer cells are highly dependent on glycolysis. Our aim was to determine if switching metabolism from glycolysis towards mitochondrial respiration would reduce growth preferentially in colorectal cancer cells over normal cells, and to examine the underlying mechanisms. Representative colorectal cancer and non-cancerous cell lines were treated with dichloroacetate (DCA), an inhibitor of pyruvate dehydrogenase kinase. Dichloroacetate (20 mM) did not reduce growth of non-cancerous cells but caused significant decrease in cancer cell proliferation (P=0.009), which was associated with apoptosis and G(2) phase cell-cycle arrest. The largest apoptotic effect was evident in metastatic LoVo cells, in which DCA induced up to a ten-fold increase in apoptotic cell counts after 48 h. The most striking G(2) arrest was evident in well-differentiated HT29 cells, in which DCA caused an eight-fold increase in cells in G(2) phase after 48 h. Dichloroacetate reduced lactate levels in growth media and induced dephosphorylation of E1alpha subunit of pyruvate dehydrogenase complex in all cell lines, but the intrinsic mitochondrial membrane potential was reduced in only cancer cells (P=0.04). Pyruvate dehydrogenase kinase inhibition attenuates glycolysis and facilitates mitochondrial oxidative phosphorylation, leading to reduced growth of colorectal cancer cells but not of non-cancerous cells.

MeSH Terms
Apoptosis/drug effects Cell Cycle/drug effects Cell Line, Tumor Cell Proliferation/drug effects Colorectal Neoplasms/pathology Dichloroacetic Acid/pharmacology Enzyme Inhibitors/pharmacology G2 Phase/drug effects Humans Lactic Acid/metabolism Oxygen/metabolism Protein Serine-Threonine Kinases/antagonists & inhibitors Pyruvate Dehydrogenase Acetyl-Transferring Kinase
Chemicals
Enzyme Inhibitors Pyruvate Dehydrogenase Acetyl-Transferring Kinase Lactic Acid Dichloroacetic Acid Protein Serine-Threonine Kinases Oxygen
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Madhok B M
Section of Translational Anaesthesia & Surgery, University of Leeds, Level 7 Clinical Sciences Building, St. James's University Hospital, Leeds, UK. [email protected]
Yeluri S
Perry S L
Hughes T A
Jayne D G
References (26)
26 references, click to expand
  1. G2 cell cycle arrest and apoptosis are induced in Burkitt's lymphoma cells by the anticancer agent oracin.
    FEBS Lett. 1997 Jan 2;400(1):127-30 PMID: 9000527
  2. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells.
    Am J Physiol Cell Physiol. 2007 Jan;292(1):C125-36 PMID: 16971499
  3. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.
    Cancer Cell. 2007 Jan;11(1):37-51 PMID: 17222789
  4. Monitoring phosphorylation of the pyruvate dehydrogenase complex.
    Anal Biochem. 2009 Jun 15;389(2):157-64 PMID: 19341700
  5. The pharmacology of dichloroacetate.
    Metabolism. 1989 Nov;38(11):1124-44 PMID: 2554095
  6. Expression patterns of hypoxic markers at the invasive margin of colorectal cancers and liver metastases.
    Eur J Surg Oncol. 2009 Dec;35(12):1286-94 PMID: 19540709
  7. The human tumor microenvironment: invasive (needle) measurement of oxygen and interstitial fluid pressure.
    Semin Radiat Oncol. 2004 Jul;14(3):249-58 PMID: 15254868
  8. On the origin of cancer cells.
    Science. 1956 Feb 24;123(3191):309-14 PMID: 13298683
  9. Dichloroacetate induces apoptosis in endometrial cancer cells.
    Gynecol Oncol. 2008 Jun;109(3):394-402 PMID: 18423823
  10. Why do cancers have high aerobic glycolysis?
    Nat Rev Cancer. 2004 Nov;4(11):891-9 PMID: 15516961
  11. Metabolic targeting as an anticancer strategy: dawn of a new era?
    Sci STKE. 2007 Apr 10;2007(381):pe14 PMID: 17426345
  12. Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis.
    Mol Cell Proteomics. 2006 Jun;5(6):1119-30 PMID: 16554294
  13. Activation of pyruvate dehydrogenase in perfused rat heart by dichloroacetate (Short Communication).
    Biochem J. 1973 Jun;134(2):651-3 PMID: 16742828
  14. Clinical pharmacology and toxicology of dichloroacetate.
    Environ Health Perspect. 1998 Aug;106 Suppl 4:989-94 PMID: 9703483
  15. Laser microdissection expression profiling of marginal edges of colorectal tumours reveals evidence of increased lactate metabolism in the aggressive phenotype.
    Gut. 2009 Mar;58(3):404-12 PMID: 18978174
  16. Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo.
    Breast Cancer Res Treat. 2010 Feb;120(1):253-60 PMID: 19543830
  17. Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex.
    Biochem J. 1998 Jan 1;329 ( Pt 1):191-6 PMID: 9405293
  18. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer.
    Br J Cancer. 2008 Oct 7;99(7):989-94 PMID: 18766181
  19. The role of hypoxia in recurrence following resection of Dukes' B colorectal cancer.
    Int J Colorectal Dis. 2008 Nov;23(11):1049-55 PMID: 18594846
  20. Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?
    J Bioenerg Biomembr. 2007 Jun;39(3):251-7 PMID: 17624581
  21. Primary prevention of colorectal cancer. The WHO Collaborating Centre for the Prevention of Colorectal Cancer.
    Bull World Health Organ. 1990;68(3):377-85 PMID: 2203551
  22. Cancer's craving for sugar: an opportunity for clinical exploitation.
    J Cancer Res Clin Oncol. 2009 Jul;135(7):867-77 PMID: 19415328
  23. Efficacy of dichloroacetate as a lactate-lowering drug.
    J Clin Pharmacol. 2003 Jul;43(7):683-91 PMID: 12856382
  24. Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation.
    Prostate. 2008 Aug 1;68(11):1223-31 PMID: 18465755
  25. Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature.
    Int J Radiat Oncol Biol Phys. 1989 Jul;17(1):91-9 PMID: 2745213
  26. Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance.
    Electrophoresis. 2009 Jun;30(12):2182-92 PMID: 19582719
Article Info
Journal
British journal of cancer
Abbr.
Br J Cancer
ISSN
1532-1827
Published
2010-06-08
Epub
2010-00-18
Pages
1746-52
Language
English
Region
England
NLM ID
0370635
PMCID
PMC2883702
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]